Business Daily from THE HINDU group of publications
Wednesday, Mar 11, 2009
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Home Page - Cigarettes
Corporate - Society & Development
Industry & Economy - Health
Agri-Biz & Commodities - Tobacco
Pfizer joins Govt’s anti-tobacco efforts

KICK THE BUTT.


P.T. Jyothi Datta

Mumbai, March 10 Smokers trying to snuff out their habit will increasingly find more support, with 1,200 more tobacco-cessation centres set to come up in the country.

The Centre has a plan for about 600 smoking-cessation clinics in districts and medical colleges, the Union Health Minister, Dr Anbumani Ramadoss, recently said, without indicating a time frame.

Government-run clinics counsel smokers to kick the butt. But cessation products are not part of these programmes, as the price is prohibitive, a Union Health Ministry official told Business Line. Nevertheless, the Centre is talking to Pfizer for a couple of pilot studies, the official added.

600 clinics

Meanwhile, multinational drugmaker Pfizer, which launched its tobacco-cessation product Champix in India last year, will set up 600 cessation clinics by 2010. Pfizer will partner with Max Healthcare to run the cessation clinics in and around New Delhi.

Pfizer is also talking to other hospitals and private practitioners across the country to partner with them for more centres.

At Max’s cessation centres, the programme includes five physician visits and 11 visits from specialists including psychologists and psychiatrists for counselling, monitoring and treatment using Champix, said Dr Sandeep Budhiraja of Max Healthcare. The programme costs about Rs 13,000.

Champix for three months costs the smoker Rs 9,000, Pfizer officials said.

Lauding the public health initiative, Dr Srinath Reddy of Public Health Foundation of India observed that the cost of cessation products was a concern. It must be made easier for the consumer, he added.

Counselling delivers results, said Dr P.C. Gupta, Director of Healis Sekhsaria Institute for Public Health. But the price of cessation products was worrisome, he added.

With 120 million tobacco users in India, the cessation clinics have their task clearly charted out.

Related Stories:
Workplaces will soon be smoke-free

More Stories on : Cigarettes | Society & Development | Health | Tobacco | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page




Stories in this Section
‘Low’ weakens, rains converge over Tamil Nadu coast


US economy: Could recession turn depression?
Job losses now spreading to non-export sectors
Outlook bullish for crude in the medium term
Partner for overseas assets: Wait to get longer for Essar Oil
Pfizer joins Govt’s anti-tobacco efforts
Chip industry: Gartner sees 45% drop in capital equipment spending
NSE software to challenge ODIN of Financial Tech
Nasscom voices concern over H-1B norms restriction
IPL revenue already tops last year’s
Quietly cognisant


Smartbuy




The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line